Cargando…

Potential Benefits of Second-Generation Human Papillomavirus Vaccines

BACKGROUND: Current prophylactic vaccines against human papillomavirus (HPV) target two oncogenic types (16 and 18) that contribute to 70% of cervical cancer cases worldwide. Our objective was to quantify the range of additional benefits conferred by second-generation HPV prophylactic vaccines that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiatpongsan, Sorapop, Campos, Nicole Gastineau, Kim, Jane J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492348/ https://www.ncbi.nlm.nih.gov/pubmed/23144879 http://dx.doi.org/10.1371/journal.pone.0048426

Ejemplares similares

Costs and Cost-Effectiveness of 9-Valent Human Papillomavirus (HPV) Vaccination in Two East African Countries
por: Kiatpongsan, Sorapop, et al.
Publicado: (2014)

Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer
por: Kitkumthorn, Nakarin, et al.
Publicado: (2006)

Human papillomavirus vaccine – lower risk, higher benefit
por: Mondal, Shaikat, et al.
Publicado: (2020)

Induction of neutralizing antibodies by human papillomavirus vaccine generated in mammalian cells
por: Wu, Xilin, et al.
Publicado: (2019)

Cost Effectiveness of a Potential Vaccine for Human papillomavirus
por: Sanders, Gillian D., et al.
Publicado: (2003)

Low Uptake of the Second Dose of Human Papillomavirus Vaccine in Dar es Salaam, Tanzania
por: Nhumba, Nchang’wa, et al.
Publicado: (2022)

Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis
por: Bogaards, Johannes A, et al.
Publicado: (2015)

Awareness of human papillomavirus and reported human papillomavirus vaccine uptake in a high-risk population
por: Amboree, Trisha L., et al.
Publicado: (2022)

Human papillomavirus vaccine
por: Singhal, Priyanka, et al.
Publicado: (2009)

Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States
por: Kim, Jane J, et al.
Publicado: (2009)

Current status of human papillomavirus vaccines
por: Kim, Kwang Sung, et al.
Publicado: (2014)

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country
por: Burger, Emily A., et al.
Publicado: (2018)

Perceptions of nurses on human papillomavirus vaccinations in the Republic of Korea
por: Kim, Hae Won, et al.
Publicado: (2019)

Evaluating Human Papillomavirus Vaccination Programs
por: Taira, Al V., et al.
Publicado: (2004)

Knowledge about human papillomavirus and the human papillomavirus vaccine in Belgian students
por: Deriemaeker, Hanne, et al.
Publicado: (2014)

Carcinogenic risk of human papillomavirus (HPV) genotypes and potential effects of HPV vaccines in Korea
por: Park, Eunhyang, et al.
Publicado: (2019)

Human Papillomavirus Vaccination Strategies
por: Cachafeiro, Santiago Pérez
Publicado: (2007)

Vaccination against human papillomavirus
por: Mello, Claudia Figueiredo
Publicado: (2013)

Adolescent Male Human Papillomavirus Vaccination
por: Nanagas, Vivian C., et al.
Publicado: (2016)

Model for Assessing Human Papillomavirus Vaccination Strategies
por: Elbasha, Elamin H., et al.
Publicado: (2007)

Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling study
por: Landy, Rebecca, et al.
Publicado: (2023)

Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
por: Zhou, Xu, et al.
Publicado: (2020)

Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus
por: Toh, Zheng Quan, et al.
Publicado: (2019)

Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
por: Serrano, Beatriz, et al.
Publicado: (2012)

Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination
por: Pimenta, Jeanne M, et al.
Publicado: (2013)

Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination
por: Tota, Joseph E., et al.
Publicado: (2016)

Cost-effectiveness of human papillomavirus vaccination in Germany
por: Damm, Oliver, et al.
Publicado: (2017)

The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study
por: Matthijsse, Suzette M., et al.
Publicado: (2018)

Multicenter Study of Human Papillomavirus and the Human Papillomavirus Vaccine: Knowledge and Attitudes among People of African Descent
por: Blackman, Elizabeth, et al.
Publicado: (2013)

Cost-effectiveness of different human papillomavirus vaccines in Singapore
por: Lee, Vernon J, et al.
Publicado: (2011)

‘I also want to be vaccinated!’ – adolescent boys’ awareness and thoughts, perceived benefits, information sources, and intention to be vaccinated against Human papillomavirus (HPV)
por: Grandahl, Maria, et al.
Publicado: (2018)

Knowledge of Human Papillomavirus, Risk of Anogenital Cancers, and Benefits of Vaccination: A Medical Student Survey in Saudi Arabia
por: Almutairi, Salman N, et al.
Publicado: (2019)

Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports
por: Jørgensen, Lars, et al.
Publicado: (2020)

Ethnic differences in human papillomavirus awareness and vaccine acceptability
por: Marlow, L A V, et al.
Publicado: (2009)

Human papillomavirus vaccination: where to now?
por: Garland, S M
Publicado: (2011)

Human papillomavirus vaccination: the population impact
por: Lee, Lai-yang, et al.
Publicado: (2017)

Human Papillomavirus Vaccines: An Updated Review
por: Cheng, Liqin, et al.
Publicado: (2020)

Human Papillomavirus: Oral Lesions and Vaccination
por: Di Spirito, Federica
Publicado: (2023)

Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects
por: Hoes, Joske, et al.
Publicado: (2020)

Variation in Human Papillomavirus Vaccination Effectiveness in the US by Age at Vaccination
por: Egemen, Didem, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b8shnagjsifj1usvgt2g7coort